LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

LLY

903

-1.58%↓

JNJ

235.46

-0.93%↓

ABBV

204.23

-0.92%↓

NVS

145.89

-1.52%↓

AZN

183.37

-2.88%↓

Home・Akciju saraksts・Charles River Laboratories International Inc

Charles River Laboratories International Inc

Slēgts

SektorsVeselības aprūpe

152.44 -0.34

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

150.41

Max

155.54

Galvenie mērījumi
By Trading Economics
Ienākumi	-332M -277M
Pārdošana	-11M 994M
EPS	2.43
Peļņas marža	-27.816
Darbinieki	18,300
EBITDA	730K 198M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	+31.05% upside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 6. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	-460M 7.5B
Iepriekšējā atvēršanas cena	152.78
Iepriekšējā slēgšanas cena	152.44

Ziņu noskaņojums

By Acuity

50%

165 / 350 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Strong Bullish Evidence

117.16 / 144.77 Atbalsts un pretestība

Charles River Laboratories International Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 20. marts 17:19 UTC

Galvenie ziņu notikumi

Chubb to Assume Risk, Issue Policies for $20 Billion Strait of Hormuz Insurance Facility

2026. g. 20. marts 16:56 UTC

Galvenie ziņu notikumi

Week Ahead for FX, Bonds: PMI Data to Show Middle East War's Impact on Sentiment

2026. g. 20. marts 16:56 UTC

Galvenie ziņu notikumi

Week Ahead for FX, Bonds: PMI Data to Show Middle -2-

2026. g. 20. marts 16:45 UTC

Galvenie ziņu notikumi

The Week in Oil: U.S. Seeks to Ease Concerns Over War But Supply Risks Mount

2026. g. 20. marts 16:22 UTC

Galvenie ziņu notikumi

NYMEX Overview: Petroleum Futures Rise, Leaving Most Contracts on Track for Solid Weekly Gains -- OPIS

2026. g. 20. marts 20:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 20. marts 20:50 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Health Care Roundup: Market Talk

2026. g. 20. marts 19:55 UTC

Tirgus saruna

Galvenie ziņu notikumi

Brent Crude Closes Out Volatile Week Higher -- Market Talk

2026. g. 20. marts 19:28 UTC

Tirgus saruna

Galvenie ziņu notikumi

Natural Gas Falls as Traders Sell Ahead of the Weekend -- Market Talk

2026. g. 20. marts 19:28 UTC

Iegādes, apvienošanās, pārņemšana

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026. g. 20. marts 18:39 UTC

Tirgus saruna

Gold Settles With Largest Weekly Dollar Decline on Record -- Market Talk

2026. g. 20. marts 18:31 UTC

Iegādes, apvienošanās, pārņemšana

Honeywell Announces Pricing of Debt Tender Offers >HON

2026. g. 20. marts 18:19 UTC

Iegādes, apvienošanās, pārņemšana

Why Mayo and Soap No Longer Mix for Unilever -- Update

2026. g. 20. marts 18:15 UTC

Tirgus saruna

iMarkets May Be Wrong in Pricing for Canadian Rate Increases -- Market Talk

2026. g. 20. marts 17:57 UTC

Tirgus saruna

U.S. Oil Rig Count Inches Up -- Market Talk

2026. g. 20. marts 17:04 UTC

Galvenie ziņu notikumi

Chubb to Assume Risk, Issue Policies for $20B Strait of Hormuz Insurance Facility

2026. g. 20. marts 16:20 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 20. marts 16:20 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Health Care Roundup: Market Talk

2026. g. 20. marts 15:40 UTC

Tirgus saruna

Iegādes, apvienošanās, pārņemšana

Unilever, McCormick Deal Makes Strategic Sense, But Risk Remains -- Market Talk

2026. g. 20. marts 15:30 UTC

Peļņas

Gemini Space Station's Earnings 'Better Than Feared.' Can They Save the Stock? -- Barrons.com

2026. g. 20. marts 15:26 UTC

Tirgus saruna

Peļņas

Galvenie ziņu notikumi

Lands' End: War Impacts Weighing on Some European Consumers -- Market Talk

2026. g. 20. marts 15:26 UTC

Iegādes, apvienošanās, pārņemšana

Why Mayo and Soap No Longer Mix for Unilever -- WSJ

2026. g. 20. marts 15:25 UTC

Tirgus saruna

Gilt Selloff Shows Vulnerability of U.K.'s Economy -- Market Talk

2026. g. 20. marts 15:19 UTC

Tirgus saruna

Galvenie ziņu notikumi

UBS Raises Oil Price Forecast as Middle East Conflict Escalates -- Market Talk

2026. g. 20. marts 14:58 UTC

Galvenie ziņu notikumi

Chevron Jumps Into Top 20 Most Valuable U.S. Companies. The Iran War's Other Big Stock Movers. -- Barrons.com

2026. g. 20. marts 14:55 UTC

Tirgus saruna

Galvenie ziņu notikumi

Gold Lower as Speculative Pullback Extends -- Market Talk

2026. g. 20. marts 14:54 UTC

Iegādes, apvienošanās, pārņemšana

Ecolab Buys CoolIT Systems for $4.75 Billion. It's All About AI for the Struggling Stock. -- Barrons.com

2026. g. 20. marts 14:53 UTC

Iegādes, apvienošanās, pārņemšana

Unilever, McCormick Deal Would Create a New Condiment King -- WSJ

2026. g. 20. marts 14:46 UTC

Tirgus saruna

U.K. Government Bonds Selloff More Pronounced Than Peers -- Market Talk

2026. g. 20. marts 14:45 UTC

Tirgus saruna

Galvenie ziņu notikumi

Oil Price Forecasts For 2026-27 Raised at UBS -- Market Talk

Salīdzinājums

Cenas izmaiņa

Charles River Laboratories International Inc Prognoze

Cenas mērķis

By TipRanks

31.05% augšup

Prognoze 12 mēnešiem

Vidējais 205.89 USD 31.05%

Augstākais 265 USD

Zemākais 175 USD

Pamatojoties uz 11 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Charles River Laboratories International Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

11 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 11 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam Charles River Laboratories International Inc — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

117.16 / 144.77Atbalsts un pretestība

Recent bullish events outweigh bearish events.

All events are bearish.

Noskaņojums

By Acuity

165 / 350 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par Charles River Laboratories International Inc

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment also offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It also provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.